Keyword: Stanford University
One of the founding scientists of Illumina has come out with a new gene-sequencing software startup that aims to tackle antimicrobial resistance.
TG Therapeutics will fund and run early-phase clinical trials of the treatment for hematologic B-cell malignancies.
Stanford scientists are using CRISPR to model individual patients’ hearts and identify which gene variants raise their risk of sudden cardiac death.
Biotech developments over the past week include using circulating RNA to predict preemie births and a new way to free up stiffened heart muscle.
Scientists in the U.S. and Japan devised a new tissue engineering method to tackle blood supply problems in pancreatic cell transplantation.
A new gene-editing tool is designed to act like the search-and-replace function in word processing, precisely cutting out genetic variants.
Calls are growing for a new approach to p-values.
Two studies uncover links between genes and brain-cell functioning that could provide new targets for therapies aimed at neurodegenerative diseases.
Researchers at Stanford used the gene editing system CRISPR-Cas9 to uncover a gene that, when impeded, may prevent neuron death in ALS.
CRISPR is a promising treatment for blood disorders, but it comes with challenges, such as off-target effects.